Picture1.jpg
Oncotelic Presenting at BiotechGate Digital Partnering
January 19, 2022 09:05 ET | Oncotelic Therapeutics, Inc.
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is currently undergoing a phase 1b trial in combination...